Clinical trials
Withdrawn Phase 4 Major Depressive Disorder trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
11 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 1 |
| 2011 | 1 |
| 2012 | 1 |
| 2013 | 2 |
| 2017 | 1 |
| 2019 | 1 |
| 2020 | 2 |
| 2022 | 1 |
| 2023 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Withdrawn | 11 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Alto Neuroscience | 2 |
| University of Utah | 2 |
| Massachusetts General Hospital | 1 |
| New York State Psychiatric Institute | 1 |
| Nova Scotia Health Authority | 1 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 |
| Todd Doyle | 1 |
| VA Office of Research and Development | 1 |
| Wyeth is now a wholly owned subsidiary of Pfizer | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Major Depressive Disorder | 11 |
| Diabetes Mellitus, Type 2 | 2 |
| Anxiety Disorders | 1 |
| Bipolar Disorder | 1 |
| Depressive Disorder | 1 |
| Diabetes Mellitus | 1 |
| Dysthymic Disorder | 1 |
Trials
Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.